Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vijver, Marc Van De"'
Autor:
Bosma, Sophie C.J., Leij, Femke, Vreeswijk, Sandra, Maaker, Michiel de, Wesseling, Jelle, Vijver, Marc van de, Scholten, Astrid, Rivera, Sofia, Bourgier, Celine, Auzac, Guillaume, Foukakis, Theodoros, Lekberg, Tobias, Bongard, Desiree, Loo, Claudette, Rutgers, Emiel, Bartelink, Harry, Elkhuizen, Paula H.M.
Publikováno v:
In International Journal of Radiation Oncology, Biology, Physics 1 April 2020 106(5):958-967
Autor:
Cuppen, Edwin, Vijver, Marc Van De, Butter, Rogier, Frederix, Geert, Aerts, Joachim, Voest, Emile, Haar, Joris Van Der, Mankor, Joanne, Coupé, Veerle, Joore, Manuela, Retèl, Valesca, Groot, Carin Uyl-De, Harten, Wim Van, Simons, Martijn, Ven, Michiel Van De, Koffijberg, Erik, Ploem, Corrette, Mitchell, Colin, Gevers, Sjef, Mfumbilwa, Zakile, Notohardjo, Jessica, IJzerman, Maarten
Presentation of all work packages at the TANGO project mini symposium in 2020, includes milestone achievements and preliminary/advanced results adjusted for public consumption.
The "Technology Assessment of Next Generation Sequencing in Personal
The "Technology Assessment of Next Generation Sequencing in Personal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e22142cf9e071ef9f30bacf7548b5af
Autor:
Cuppen, Edwin, Vijver, Marc Van De, Butter, Rogier, Frederix, Geert, Aerts, Joachim, Voest, Emile, Haar, Joris Van Der, Mankor, Joanne, Coupé, Veerle, Joore, Manuela, Feenstra, Talitha, Retèl, Valesca, Groot, Carin Uyl-De, Harten, Wim Van, Simons, Martijn, Ven, Michiel Van De, Koffijberg, Erik, Ploem, Corrette, Mitchell, Colin, Gevers, Sjef, Mfumbilwa, Zakile, Notohardjo, Jessica, IJzerman, Maarten
Presentation of all work packages at the TANGO project mini symposium in 2019, includes milestone achievements and preliminary results adjusted for public consumption.
The "Technology Assessment of Next Generation Sequencing in Personalized Onco
The "Technology Assessment of Next Generation Sequencing in Personalized Onco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9edb0ea784e11454215b36652bbf622a
Autor:
Retèl, Valesca, Harten, Wim Van, Joore, Manuela, IJzerman, Maarten, Koffijberg, Erik, Coupé, Veerle, Frederix, Geert, Feenstra, Talitha, Groot, Carin Uyl-De, Eekhout, Inge, Vijver, Marc Van De, Aerts, Joachim, Eertwegh, Alfonds Van Den, Smit, Egbert, Sleijfer, Stefan, Voest, Emile, Ploem, Corrette, Gevers, Sjef, Bredenoord, Annelien, Butter, Rogier, Pasmans, Clémence, Simons, Martijn, Ven, Michiel Van De, D Hurkmans, Giesbertz, Noor, Mitchell, Colin, Cuppen, Edwin
Publikováno v:
Whole Genome Sequencing in Personalized Oncology
Poster presented at Health RI conference about 'Whole Genome Sequencing in Personalized Oncology' covering rationale, goals, data flow, workflow, and relevance to HEALTH-RI.
The "Technology Assessment of Next Generation Sequencing in Personalize
The "Technology Assessment of Next Generation Sequencing in Personalize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305935f0c2e78c888b37a97af57ffdbd
Autor:
Qing-Bai She, Gruvberger-Saal, Sofia, Maurer, Matthew, Yilun Chen, Jumppanen, Mervi, Su, Tao, Dendy, Meaghan, Ying-Ka Lau, Memeo, Lorenzo, Horlings, Hugo, Vijver, Marc Van De, Isola, Jorma, Hanina Hibshoosh, Rosen, Neal, Parsons, Ramon, Saal, Lao
Chronic treatment with gefitinib and PWT-458, alone or in combination, does not cause eight loss in mice. Mice bearing MDA-MB-468 xenograft tumors were treated with PWT-458 (100 mg/kg five imes/week), gefitinib (150 mg/kg five times/week), combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4144eb2b3c90ae5e76d737651b5c1317
Autor:
Qing-Bai She, Gruvberger-Saal, Sofia, Maurer, Matthew, Yilun Chen, Jumppanen, Mervi, Su, Tao, Dendy, Meaghan, Ying-Ka Lau, Memeo, Lorenzo, Horlings, Hugo, Vijver, Marc Van De, Isola, Jorma, Hanina Hibshoosh, Rosen, Neal, Parsons, Ramon, Saal, Lao
HCC70 (A) or SUM149 (B) cells were treated with single-agent gefitinib (left) or combination treatment with 5 ÎźM LY294002 plus gefitinib at the concentrations indicated and cell proliferation measured over 4 days. (PDF 217 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9bba2adac879343501bbb95056c2dc3
Autor:
Qing-Bai She, Gruvberger-Saal, Sofia, Maurer, Matthew, Yilun Chen, Jumppanen, Mervi, Su, Tao, Dendy, Meaghan, Ying-Ka Lau, Memeo, Lorenzo, Horlings, Hugo, Vijver, Marc Van De, Isola, Jorma, Hanina Hibshoosh, Rosen, Neal, Parsons, Ramon, Saal, Lao
Chronic treatment with gefitinib and PWT-458, alone or in combination, does not cause eight loss in mice. Mice bearing MDA-MB-468 xenograft tumors were treated with PWT-458 (100 mg/kg five imes/week), gefitinib (150 mg/kg five times/week), combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7117caa26733d1dbd915f80ede59e444
Autor:
Qing-Bai She, Gruvberger-Saal, Sofia, Maurer, Matthew, Yilun Chen, Jumppanen, Mervi, Su, Tao, Dendy, Meaghan, Ying-Ka Lau, Memeo, Lorenzo, Horlings, Hugo, Vijver, Marc Van De, Isola, Jorma, Hanina Hibshoosh, Rosen, Neal, Parsons, Ramon, Saal, Lao
HCC70 (A) or SUM149 (B) cells were treated with single-agent gefitinib (left) or combination treatment with 5 ÎźM LY294002 plus gefitinib at the concentrations indicated and cell proliferation measured over 4 days. (PDF 217 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d012188a0636f73f5ac088f6bf742f84